Statin intolerance objectively identified in patients
(Cleveland Clinic) In the first major trial of its kind, Cleveland Clinic researchers used a blinded rechallenge with atorvastatin or placebo to objectively confirm the presence of muscle-related symptoms in patients with a history of intolerance to multiple statins and found that evolocumab (a PCSK9 inhibitor) was a more effective option to lower cholesterol than ezetimibe in these patients.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Atorvastatin Calcium | Cholesterol | Health | International Medicine & Public Health | Lipitor | Statin Therapy | Vytorin | Zetia | Zivast